Literature DB >> 20454521

PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.

Maria Paola Simula1, Renato Cannizzaro, Vincenzo Canzonieri, Alessandro Pavan, Stefania Maiero, Giuseppe Toffoli, Valli De Re.   

Abstract

Celiac disease (CD) is an immune-mediated disorder triggered by the ingestion of wheat gliadin and related proteins in genetically predisposed individuals. To find a proteomic CD diagnostic signature and to gain a better understanding of pathogenetic mechanisms associated with CD, we analyzed the intestinal mucosa proteome alterations using two dimensional difference gel electrophoresis (2D-DIGE) coupled with matrix assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF ms) of CD patients with varying degrees of histological abnormalities defined by Marsh criteria and controls. Our results clearly evidenced the presence of two groups of patients: Group A, including controls and Marsh 0-I CD patients; and Group B, consisting of CD subjects with grade II-III Oberhuber-Marsh classification. Differentially expressed proteins were involved mainly in lipid, protein and sugar metabolism. Interestingly, in Group B, several downregulated proteins (FABP1, FABP2, APOC3, HMGCS2, ACADM and PEPCK) were implicated directly in the peroxisome proliferator-activated receptor (PPAR) signaling pathway. Moreover, Group B patients presented a deregulation of some proteins involved in apoptosis/survival pathways: phosphatidylethanolamine-binding protein 1 (PEBP1), Ras-related nuclear protein (Ran) and peroxiredoxin 4 (PRDX4). PEBP1 downregulation and RAN and PRDX4 upregulation were associated with more severe tissue damage. Likewise, IgMs were found strongly upregulated in Group B. In conclusion, our results indicate that a downregulation of proteins involved in PPAR signaling and the modulation of several cancer-related proteins are associated with the highest CD histological score according to Oberhuber-Marsh classification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20454521      PMCID: PMC2864807          DOI: 10.2119/molmed.2009.00173

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  68 in total

Review 1.  Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Authors:  B Desvergne; W Wahli
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

2.  Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis.

Authors:  P Raman; R L Judd
Journal:  Eur J Pharmacol       Date:  2000-12-01       Impact factor: 4.432

Review 3.  Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers.

Authors:  Yasuhiro Kuramitsu; Kazuyuki Nakamura
Journal:  Proteomics       Date:  2006-10       Impact factor: 3.984

4.  Comment re: Ran-GTP control of tumor cell mitosis.

Authors:  Maria Paola Simula; Maria Dolores Marin; Laura Caggiari; Valli De Re; Renato Cannizzaro; Vincenzo Canzonieri
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

5.  Immunoglobulin secretion by isolated intestinal lymphocytes: spontaneous production and T-cell regulation in normal small intestine and in patients with coeliac disease.

Authors:  J E Crabtree; R V Heatley; M L Losowsky
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

6.  Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis.

Authors:  K Setoguchi; Y Misaki; Y Terauchi; T Yamauchi; K Kawahata; T Kadowaki; K Yamamoto
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

7.  Clofibric acid, a peroxisome proliferator-activated receptor alpha ligand, inhibits growth of human ovarian cancer.

Authors:  Yoshihito Yokoyama; Bing Xin; Tatsuhiko Shigeto; Mika Umemoto; Akiko Kasai-Sakamoto; Masayuki Futagami; Shigeki Tsuchida; Fahd Al-Mulla; Hideki Mizunuma
Journal:  Mol Cancer Ther       Date:  2007-04       Impact factor: 6.261

8.  Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells.

Authors:  V De Re; M P Simula; L Caggiari; N Orzes; M Spina; A Da ponte; L De Appollonia; R Dolcetti; V Canzonieri; R Cannizzaro
Journal:  Clin Exp Immunol       Date:  2007-03-05       Impact factor: 4.330

9.  Comparative mitochondrial proteomic analysis of Rji cells exposed to adriamycin.

Authors:  Yu-Jie Jiang; Qing Sun; Xiao-Sheng Fang; Xin Wang
Journal:  Mol Med       Date:  2009-02-05       Impact factor: 6.354

Review 10.  Emerging roles of PPARs in inflammation and immunity.

Authors:  Raymond A Daynes; Dallas C Jones
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

View more
  22 in total

Review 1.  Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies.

Authors:  Valli De Re; Maria Paola Simula; Vincenzo Canzonieri; Renato Cannizzaro
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

2.  SNPs affecting serum metabolomic traits may regulate gene transcription and lipid accumulation in the liver.

Authors:  Snezana Mirkov; Jamie L Myers; Jacqueline Ramírez; Wanqing Liu
Journal:  Metabolism       Date:  2012-06-26       Impact factor: 8.694

3.  Peroxisome proliferator-activated receptor-γ and thymic stromal lymphopoietin are involved in the pathophysiology of childhood coeliac disease.

Authors:  Erna Sziksz; Kriszta Molnár; Rita Lippai; Domonkos Pap; Anna Onody; Apor Veres-Székely; Péter Vörös; Dolóresz Szabó; Hajnalka Győrffy; Gábor Veres; Tivadar Tulassay; Adám Vannay; András Arató
Journal:  Virchows Arch       Date:  2014-09-04       Impact factor: 4.064

4.  Differential proteomics of Helicobacter pylori associated with autoimmune atrophic gastritis.

Authors:  Ombretta Repetto; Stefania Zanussi; Mariateresa Casarotto; Vincenzo Canzonieri; Paolo De Paoli; Renato Cannizzaro; Valli De Re
Journal:  Mol Med       Date:  2014-02-28       Impact factor: 6.354

Review 5.  Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Neurosci Bull       Date:  2018-03-26       Impact factor: 5.203

6.  SUMOylation regulates p27Kip1 stability and localization in response to TGFβ.

Authors:  Sara Lovisa; Simona Citro; Maura Sonego; Alessandra Dall'Acqua; Valentina Ranzuglia; Stefania Berton; Alfonso Colombatti; Barbara Belletti; Susanna Chiocca; Monica Schiappacassi; Gustavo Baldassarre
Journal:  J Mol Cell Biol       Date:  2015-10-08       Impact factor: 6.216

7.  Altered peroxisome-proliferator activated receptors expression in human endometrial cancer.

Authors:  Paweł Knapp; Adrian Chabowski; Agnieszka Błachnio-Zabielska; Katarzyna Jarząbek; Sławomir Wołczyński
Journal:  PPAR Res       Date:  2012-02-19       Impact factor: 4.964

Review 8.  Celiac disease, inflammation and oxidative damage: a nutrigenetic approach.

Authors:  Gianna Ferretti; Tiziana Bacchetti; Simona Masciangelo; Letizia Saturni
Journal:  Nutrients       Date:  2012-03-27       Impact factor: 5.717

9.  Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cells.

Authors:  Ivana Caputo; Agnese Secondo; Marilena Lepretti; Gaetana Paolella; Salvatore Auricchio; Maria Vittoria Barone; Carla Esposito
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

10.  Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.

Authors:  Ali Abbasi; Eva Corpeleijn; Douwe Postmus; Ron T Gansevoort; Paul E de Jong; Rijk O B Gans; Joachim Struck; Janin Schulte; Hans L Hillege; Pim van der Harst; Linda M Peelen; Joline W J Beulens; Ronald P Stolk; Gerjan Navis; Stephan J L Bakker
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.